π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This study will evaluate the superiority of ulipristal acetate versus place...
Status
Completed
Location
Watson Investigational Site 138
Start Date
2014-01-29
Trial ID
NCT02147158
Treatments Being Tested
This study investigates the impact of perioperative inhibition of beta-adre...
Status
Recruiting
Location
The Chaim Sheba Medical Center
Start Date
2025-03-12
Trial ID
NCT06839144
This study will evaluate the safety, tolerability, and effect of multiple d...
Status
Completed
Location
Multiple Locations
Start Date
2011-03-25
Trial ID
NCT01293006
Treatments Being Tested
The purpose of this study is to determine if bempedoic acid (ETC-1002) 180m...
Status
Completed
Location
L-MARC Research Center
Start Date
2017-04-07
Trial ID
NCT03193047
Treatments Being Tested
The purpose of this study is to determine if the addition of apalutamide to...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2015-11-27
Trial ID
NCT02489318
Treatments Being Tested
This study evaluates the effect of ecopipam tablets in children and adolesc...
Status
Completed
Location
Harmonex Neuroscience Research
Start Date
2019-06-28
Trial ID
NCT04007991
The primary objective of this study is to evaluate the safety and efficacy ...
Status
Completed
Location
UCI Center for Clinical Research
Start Date
2021-06-28
Trial ID
NCT04886518
Treatments Being Tested
The objective of this study is to determine the effect of two dose strength...
Status
Completed
Location
Acorda Site #117
Start Date
2014-12
Trial ID
NCT02271217
Treatments Being Tested
The purpose of this study is the use of Nefazodone in the treatment of coca...
Status
Completed
Location
Boston University
Start Date
1997-02
Trial ID
NCT00015210
Treatments Being Tested
GSK2798745 is a potent and selective transient receptor potential vanilloid...
Status
Terminated
Location
GSK Investigational Site
Start Date
2018-04-05
Trial ID
NCT03372603
Treatments Being Tested